CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 241 enrolled
Drug / intervention
Trident® Tritanium™ Acetabular Shelldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00535626
NCT00535626N/ACompleted
CompareCT.gov

A Post-market, Non-randomized, Open Label, Multi-center Clinical Study of the Trident Tritanium Acetabular Shell

Stryker Orthopaedics·interventional·Posted Sep 26, 2007·Updated Nov 20, 2017

In Brief

A clinical study evaluating Trident® Tritanium™ Acetabular Shell for Arthroplasty, Replacement, Hip. Completed, enrolled 241 participants across 15 sites.

Detailed Summary

The purpose of this study is to evaluate a hip implant system used when a previous hip replacement surgery has failed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasty, Replacement, Hip
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 26, 2007
Enrollment StartNov 1, 2006
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9.8 yearsPosted 18.8 years ago

Interventions

Trident® Tritanium™ Acetabular Shelldevice

Trident® Tritanium™ Acetabular Shell